Skip to main content
  • Home
  • HealthQuest Capital
Institutional profile

HealthQuest Capital

HealthQuest Capital invests in commercial-stage healthcare innovation across medical devices, diagnostics, digital health, healthcare services, and related technologies.

Official website

  • Healthcare and biotechnology venture capital investor
  • Healthcare & BioTech Venture Capital
  • Tier III

Overview

HealthQuest Capital invests in commercial-stage healthcare innovation across medical devices, diagnostics, digital health, healthcare services, and related technologies. It focuses on products and business models that can improve outcomes, efficiency, access, or cost within healthcare systems.

The firm is especially relevant where companies have moved beyond initial technical validation and need support with adoption, reimbursement, channel development, market expansion, and growth financing. Within The Economy Wiki, the institution is connected to the Healthcare & Biotechnology Venture Capital market category.

Firm facts

InstitutionHealthQuest Capital
TypeHealthcare and biotechnology venture capital investor
HeadquartersSan Francisco Bay Area, United States
Founded2012
Primary ranking focusHealthcare & BioTech Venture Capital
Highest 2026 tierTier III

Activities and investment capabilities

HealthQuest Capital operates within life-sciences innovation, clinical development and healthcare company building. Its category-specific capabilities are summarized below.

Life-sciences investing

Capital for therapeutics, diagnostics, medical devices and research platforms.

Clinical development

Support across scientific validation, trials, regulation and commercialization.

Healthcare innovation

Investment in care delivery, health technology and data-enabled medical businesses.

Strategy and market coverage

Stage and strategy coverage

Company formation through growth; translational research; clinical and commercial financing

Sector and market coverage

Biotechnology; therapeutics; diagnostics; medtech; digital health and healthcare services

Market position

HealthQuest fits Tier III because its orientation is later and more commercially focused than that of biotech venture creators. Its category breadth and practical healthcare-market expertise strengthen the ranking’s coverage of medtech and delivery innovation.

HealthQuest Capital is assessed within the Healthcare & Biotechnology Venture Capital framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

HealthQuest Capital is recognized Tier III in Top 30 Healthcare & BioTech Venture Capital 2026. The rankings compare institutions by market relevance, investment or operating capability, sector and stage expertise, institutional credibility and current activity. Comparable links support navigation and do not imply that every institution competes for every company, fund commitment or transaction.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through the institution’s official website.

Leadership areaCurrent source
Investment and operating leadershipCurrent team and governance information

Corporate and public information

This profile refers to HealthQuest Capital as the public-facing organization. Individual funds, management companies, advisers, lending entities, broker-dealers and regulated affiliates may use separate legal names across jurisdictions.

Corporate and disclosure information
OrganizationHealthQuest Capital
HeadquartersSan Francisco Bay Area, United States
Public websitewww.healthquestcapital.com
Profile basisPublic institutional information and Capital Ranking editorial research

Ranking recognition

Related Economy analysis

Selected Economy Markets articles provide context for the venture, financing, diligence and private-market themes relevant to this institution:

Sources

  1. HealthQuest Capital — official website
  2. Capital Ranking — Top 30 Healthcare & BioTech Venture Capital 2026

First published: 28 August 2026

Last reviewed: 28 August 2026

Profile scope: Healthcare & BioTech Venture Capital

This page is an editorial reference and does not constitute investment, legal, credit-rating or regulatory advice.